We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Mirati Therapeutics Inc | NASDAQ:MRTX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 58.70 | 58.90 | 58.70 | 0 | 01:00:00 |
From Jun 2023 to Jun 2024
--Sanofi is considering a potential acquisition of Mirati Therapeutics Inc., a San Diego-based biotechnology company focused on cancer drugs, Bloomberg reports, citing unnamed sources.
--Mirati could draw interest from other suitors and there is no certainty that the French pharmaceutical giant's deliberations will result in a deal, according to Bloomberg.
--Sanofi and Mirati didn't immediately respond to requests for comment from Dow Jones Newswires.
Full story: https://shorturl.at/lIR39
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
October 06, 2023 02:41 ET (06:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Mirati Therapeutics Chart |
1 Month Mirati Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
